How Much Bacteriostatic Water for Dihexa? (Chart)
Determining the precise diluent volume for reconstituting Dihexa in a laboratory setting depends directly on the desired final working concentration (mg/mL) required for your specific in vitro or preclinical assay protocol. For standard research applications involving 10 mg or 20 mg vial sizes, researchers routinely reconstitute using 1.0 mL to 2.0 mL of sterile bacteriostatic water to achieve working stock concentrations ranging from 5.0 mg/mL to 20.0 mg/mL.
Quick answer
Determining the precise diluent volume for reconstituting Dihexa in a laboratory setting depends directly on the desired final working concentration (mg/mL) required for your specific in vitro or preclinical assay protocol. For standard research applications involving 10 mg or 20 mg vial sizes, researchers routinely reconstitute using 1.0 mL to 2.0 mL of sterile bacteriostatic water to achieve working stock concentrations ranging from 5.0 mg/mL to 20.0 mg/mL.
Key takeaways
- Determining how much bacteriostatic water for [dihexa](/research-peptides/dihexa) depends on your targeted laboratory concentration (mg/mL), but standard protocols typically utilize 1.0 mL to 2.0 mL of bacteriostatic water per 10 mg or 20 mg vial to yield concentrations between 5 mg/mL and 20 mg/mL.
- The matrix below outlines standard reconstitution parameters for common laboratory vial masses of [Dihexa](/research-peptides/dihexa) when using sterile bacteriostatic water.
- Calculating concentration after reconstituting a lyophilized research compound follows basic quantitative stoichiometry.
- [Dihexa](/research-peptides/dihexa) is an angiotensin IV-derived hexapeptide analog synthesized to demonstrate high stability and affinity toward hepatocyte growth factor (HGF) and its receptor c-Met in preclinical models.
Reconstitution Diluent Volume Determination for Dihexa
Determining how much bacteriostatic water for dihexa depends on your targeted laboratory concentration (mg/mL), but standard protocols typically utilize 1.0 mL to 2.0 mL of bacteriostatic water per 10 mg or 20 mg vial to yield concentrations between 5 mg/mL and 20 mg/mL. Because Dihexa (N-hexanoic-Tyr-Ile-Ala-aminohexanoic amide) is an oligopeptide derivative evaluated in neurobiological models, maintaining exact quantitative control over liquid volumes is vital for reproducible dosing in cell culture, tissue baths, or animal model research.
When preparing lyophilized Dihexa for experimental assays, selecting the correct diluent volume requires balancing stock solubility, volumetric accuracy, and downstream dilution constraints. Utilizing our interactive reconstitution calculator allows researchers to rapidly compute exact microliter allocations based on total lyophilized mass and target milligram-per-milliliter ratios.
While bacteriostatic water (0.9% benzyl alcohol preserved sterile water) is standard for maintaining microbiological sterility across multi-use laboratory stock vials, researchers must also evaluate the specific physical solubility profile of Dihexa. Higher mass concentrations may require specific reconstitution techniques or co-solvent considerations depending on the experimental buffer system utilized downstream.
Dihexa Reconstitution Volume & Concentration Reference Chart
The matrix below outlines standard reconstitution parameters for common laboratory vial masses of Dihexa when using sterile bacteriostatic water. Researchers evaluating diverse experimental concentrations can cross-reference total vial mass against added diluent volume to establish target stock concentrations (mg/mL) and microgram concentrations per unit volume (mcg/µL).
| Vial Mass (mg) | Added BAC Water (mL) | Resulting Concentration (mg/mL) | Concentration per 0.1 mL (10 Units) | Concentration per µL | |---|---|---|---|---| | 10 mg | 1.0 mL | 10.0 mg/mL | 1.0 mg | 10.0 µC/µL | | 10 mg | 2.0 mL | 5.0 mg/mL | 0.5 mg | 5.0 µg/µL | | 10 mg | 5.0 mL | 2.0 mg/mL | 0.2 mg | 2.0 µg/µL | | 20 mg | 1.0 mL | 20.0 mg/mL | 2.0 mg | 20.0 µg/µL | | 20 mg | 2.0 mL | 10.0 mg/mL | 1.0 mg | 10.0 µg/µL | | 20 mg | 4.0 mL | 5.0 mg/mL | 0.5 mg | 5.0 µg/µL | | 50 mg | 2.5 mL | 20.0 mg/mL | 2.0 mg | 20.0 µg/µL | | 50 mg | 5.0 mL | 10.0 mg/mL | 1.0 mg | 10.0 µg/µL |
For alternative dosage forms or oral administration studies in preclinical models, researchers may also explore pre-formulated solid research options such as dihexa capsules 10mg or explore our complete catalog of all peptides for alternative research compounds.
The Mathematical Formula Behind Reconstitution Calculations
Calculating concentration after reconstituting a lyophilized research compound follows basic quantitative stoichiometry. The fundamental equation governing liquid stock preparations is Concentration (C) = Mass (m) / Volume (V). When working with Dihexa, expressing mass in milligrams (mg) and volume in milliliters (mL) yields a working stock concentration in mg/mL.
For instance, if a researcher dissolves a 10 mg vial of Dihexa in 2.0 mL of diluent, the mathematical calculation is: C = 10 mg / 2.0 mL = 5.0 mg/mL. If an assay protocol specifies a 500 microgram (0.5 mg) treatment per test well, the required micropipette volume is calculated as: Volume = Target Mass / Stock Concentration = 0.5 mg / 5.0 mg/mL = 0.10 mL (or 100 µL).
Standardizing these calculations across high-throughput laboratory workflows minimizes pipetting errors and ensures inter-assay consistency. High-precision analytical balances and calibrated adjustable micropipettes should always be employed when verifying liquid transfers in laboratory environments.
Physico-Chemical Properties and Solubilization Dynamics of Dihexa
Dihexa is an angiotensin IV-derived hexapeptide analog synthesized to demonstrate high stability and affinity toward hepatocyte growth factor (HGF) and its receptor c-Met in preclinical models. Structurally optimized with N-terminal hexanoyl modifications, Dihexa exhibits distinct lipophilic and hydrophilic characteristics compared to native unmodified peptides.
While Dihexa readily dissolves in aqueous solutions containing 0.9% benzyl alcohol (bacteriostatic water) at moderate concentrations (e.g., 5–10 mg/mL), higher stock concentrations (≥20 mg/mL) may demonstrate slower dissolution rates. In vitro studies indicate that gentle room-temperature vortexing or short exposure to a temperature-controlled sonication bath facilitates complete solubilization without degrading the peptide backbone.
Researchers working with physiological buffer systems (such as Phosphate-Buffered Saline or Cell Culture Media) should reconstitute lyophilized Dihexa in bacteriostatic water or dimethyl sulfoxide (DMSO) first to create a primary stock before making final working dilutions in culture media. This prevents precipitation that can occur when adding dry lyophilisate directly to complex salt-containing media.
Step-by-Step Laboratory Reconstitution Protocol
Reconstituting Dihexa must be executed within a certified laminar flow hood or clean bench using aseptic technique to protect the sample from microbial and enzymatic degradation. Below is the standard operating protocol for reconstituting a vial for analytical research:
1. Clean the work surface with 70% isopropyl alcohol and allow it to air dry. Gather the Dihexa vial, sterile bacteriostatic water, alcohol prep pads, and sterile single-use syringes with low-dead-space needles. 2. Swab the rubber stoppers of both the bacteriostatic water vial and the Dihexa vial with an alcohol wipe and allow them to dry completely. 3. Using a sterile syringe, draw up the precise calculated volume of bacteriostatic water (e.g., 2.0 mL for a 10 mg vial). 4. Carefully insert the needle through the center of the Dihexa vial stopper at a 45-degree angle, returning to 90 degrees as it penetrates to prevent coring. 5. Slowly depress the syringe plunger, directing the stream of diluent down the glass interior wall of the vial. Avoid spraying liquid directly onto the lyophilized powder cake to prevent foaming and shear stress. 6. Allow the vacuum within the vial to equalize, then withdraw the syringe. 7. Gently swirl the vial in a smooth circular motion until the lyophilized cake fully dissolves into a clear solution. Do not shake vigorously.
Inspect the reconstituted solution under adequate illumination. The liquid should be crystal clear, free of suspended particulate matter, cloudiness, or phase separation before proceeding to laboratory assays.
Aliquoting Guidance and Preventing Thermal Degradation
Repeated freeze-thaw cycles significantly accelerate peptide degradation via peptide bond cleavage, aggregation, and oxidation. Once Dihexa is reconstituted into a liquid stock solution, best laboratory practices dictate immediate aliquoting into single-use microcentrifuge tubes.
Divide the reconstituted solution into precise aliquot volumes based on daily assay requirements (e.g., 50 µL to 200 µL per sterile tube). Store aliquots destined for immediate use within 14–28 days at 2°C to 8°C. For long-term preservation spanning months, freeze aliquots at -20°C or -80°C in non-frost-free freezers to prevent temperature fluctuations.
Always label each microcentrifuge tube clearly with the compound name (Dihexa), total concentration (mg/mL), reconstitution diluent used, batch number, and date of reconstitution. This ensures complete traceability across multi-investigator research projects.
Comparative Analysis: Dihexa vs. Other Synaptogenic Research Peptides
In neurobiological research investigating synaptic plasticity, dendritic spine formation, and cognitive biomarkers, Dihexa is often evaluated alongside other prominent research peptides such as Semax, Selank, and NSI-189. Understanding the distinct structural properties and operational parameters of these compounds is critical for experimental design.
Preclinical studies suggest that while heptapeptide analogs like Semax target neurotrophic factors such as BDNF and NGF in CNS tissue models, Dihexa acts primarily as a potent agonist of the HGF/c-Met receptor system, facilitating synaptogenesis at picomolar concentrations in cellular models. Unlike smaller un-modified linear peptides that degrade rapidly in serum, Dihexa's hexanoyl modification provides enhanced metabolic stability, altering its handling and solubility dynamics in laboratory preparations.
When designing comparative in vitro panels, researchers must account for these mechanical differences: Semax and Selank dissolve rapidly in standard aqueous media, whereas Dihexa stocks benefit from careful volume calculation and occasional organic co-solvent assistance for high-density assays. Evaluating comparative data sheets helps ensure consistent stock preparation across distinct experimental arms.
Analytical Quality Control and Verification for Dihexa
The accuracy of reconstitution calculations is only as reliable as the stated purity and mass of the starting lyophilized compound. PX1 Research subjects every production lot of Dihexa to rigorous quality verification performed by independent ISO 17025 accredited laboratories located in the USA.
Our quality assurance process validates compound integrity through High-Performance Liquid Chromatography (HPLC) to verify chemical purity (>99.0%) and Mass Spectrometry (MS) to confirm exact molecular weight. Additionally, every batch undergoes kinetic chromogenic LAL testing to confirm endotoxin levels fall well below rigorous laboratory threshold limits (<0.05 EU/mg).
Researchers can inspect batch-specific documentation at any time by accessing our public repository of COA documentation. Receiving ultra-pure, USA-manufactured research compounds ensures that reconstitutions calculated using our reference charts translate into exact, reproducible molecular concentrations in your experiments.
Equipment and Reagent Checklist for Laboratory Reconstitution
To perform accurate, sterile reconstitutions of Dihexa without risking contamination or volumetric variance, laboratories should maintain a dedicated reagent standard operating environment. Below is a checklist of necessary supplies:
• High-purity lyophilized Dihexa vial (PX1 Research lot-verified) • Sterile Bacteriostatic Water (0.9% benzyl alcohol preserved) • ISO-calibrated adjustable micropipettes (0.5–10 µL, 20–200 µL, 100–1000 µL) • Sterile filter micropipette tips (DNase/RNase/pyrogen-free) • 70% Isopropyl alcohol wipes and surface disinfectant • Sterile 1.5 mL polypropylene microcentrifuge tubes for aliquoting • Syringes with 21G to 25G sterile needles for diluent transfer • Cryogenic storage racks and temperature-monitored freezers (-20°C/-80°C)
Utilizing high-grade polypropylene tubes prevents non-specific binding of peptide molecules to plastic container walls, maintaining absolute liquid concentration throughout storage duration.
Maintaining Assay Sterility and Preventing Microbial Contamination
Bacteriostatic water contains 0.9% benzyl alcohol, which acts as a bacteriostatic agent to inhibit the growth of most gram-positive and gram-negative bacteria, fungi, and yeasts in multi-dose aqueous preparations. However, benzyl alcohol does not eliminate pre-existing contamination introduced via improper aseptic technique.
When withdrawing multiple aliquots over extended timeframes, researchers must sanitize the vial septum prior to every insertion. If an assay involves sensitive primary neuronal cell cultures that may react adversely to trace benzyl alcohol, researchers should reconstitute Dihexa using sterile 0.9% Normal Saline or sterile Water for Injection (WFI), immediately aliquoting and freezing unused portions at -80°C to maintain sterility without preservatives.
For bulk assay requirements or specialized research institution ordering, explore our wholesale account solutions to source bulk laboratory reagents and high-volume peptide lots backed by complete analytical verification.
Frequently Asked Questions
How much bacteriostatic water should I add to a 10 mg vial of Dihexa?
Adding 1.0 mL of bacteriostatic water to a 10 mg vial yields a stock concentration of 10.0 mg/mL (1.0 mg per 0.1 mL). Adding 2.0 mL yields a concentration of 5.0 mg/mL (0.5 mg per 0.1 mL). Select the volume based on your target microgram concentration per microliter required for your assay.
Can Dihexa be reconstituted with plain sterile water instead of bacteriostatic water?
Yes, sterile Water for Injection (WFI) or sterile 0.9% saline can be used. However, without 0.9% benzyl alcohol as a preservative, the reconstituted solution must be aliquoted immediately and stored at -20°C or -80°C, as it lacks protection against microbial growth during repeated sampling.
Why is Dihexa slow to dissolve in bacteriostatic water?
Dihexa contains an N-terminal hexanoyl modification that increases its lipophilicity compared to traditional hydrophilic peptides. If dissolving at high concentrations (≥20 mg/mL), gentle swirling, room-temperature equilibration, or mild sonication will facilitate complete dissolution.
How should reconstituted Dihexa stock solutions be stored?
Reconstituted liquid aliquots should be stored at 2°C to 8°C for short-term use (up to 28 days if reconstituted with bacteriostatic water). For long-term preservation, sub-aliquot into sterile polypropylene tubes and store at -20°C or -80°C to prevent freeze-thaw degradation.
What is the molecular purity of PX1 Research Dihexa?
PX1 Research provides Dihexa synthesized in GMP-compliant, USA-based facilities with a verified purity exceeding 99.0% as confirmed by HPLC and MS analysis. Every lot is independently tested in ISO 17025 accredited laboratories.
Where can I find the Certificate of Analysis (COA) for my Dihexa lot?
Batch-specific Certificates of Analysis detailing HPLC purity profiles, Mass Spectrometry confirmation, and endotoxin assay results are accessible directly on our website via the COA documentation hub.
How do I calculate custom microliter additions for specific cell culture assays?
You can calculate custom volumes using the formula: Volume (mL) = Mass (mg) / Target Concentration (mg/mL). Alternatively, utilize the PX1 interactive reconstitution calculator online for instant volume conversions.
What endotoxin levels are acceptable for Dihexa research compounds?
PX1 Research enforces strict quality standards where endotoxin levels are verified to be under 0.05 EU/mg via chromogenic LAL assays, ensuring suitability for sensitive in vitro tissue models and cellular assays.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.